Boston Scientific Corp. (BSX)
44.99
+0.18
(+0.40%)
USD |
NYSE |
Jul 09, 16:00
45.14
+0.15
(+0.33%)
Pre-Market: 06:51
Boston Scientific Cash from Financing (Quarterly) : -260.00M for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -260.00M |
| December 31, 2025 | -184.00M |
| September 30, 2025 | -104.00M |
| June 30, 2025 | -340.00M |
| March 31, 2025 | 233.00M |
| December 31, 2024 | 214.00M |
| September 30, 2024 | 7.00M |
| June 30, 2024 | 24.00M |
| March 31, 2024 | 1.569B |
| December 31, 2023 | 15.00M |
| September 30, 2023 | 16.00M |
| June 30, 2023 | 43.00M |
| March 31, 2023 | -69.00M |
| December 31, 2022 | 1.00M |
| September 30, 2022 | -199.00M |
| June 30, 2022 | -344.00M |
| March 31, 2022 | -6.00M |
| December 31, 2021 | -8.00M |
| September 30, 2021 | 6.00M |
| June 30, 2021 | 2.00M |
| March 31, 2021 | -95.00M |
| December 31, 2020 | -819.00M |
| September 30, 2020 | -249.00M |
| June 30, 2020 | 1.105B |
| March 31, 2020 | 256.00M |
| Date | Value |
|---|---|
| December 31, 2019 | -724.00M |
| September 30, 2019 | 1.314B |
| June 30, 2019 | 256.00M |
| March 31, 2019 | 2.127B |
| December 31, 2018 | 425.00M |
| September 30, 2018 | 151.00M |
| June 30, 2018 | 726.00M |
| March 31, 2018 | 130.00M |
| December 31, 2017 | -68.00M |
| September 30, 2017 | -139.00M |
| June 30, 2017 | 332.00M |
| March 31, 2017 | -15.00M |
| December 31, 2016 | 28.00M |
| September 30, 2016 | 34.00M |
| June 30, 2016 | -217.00M |
| March 31, 2016 | -51.00M |
| December 31, 2015 | -191.00M |
| September 30, 2015 | 761.00M |
| June 30, 2015 | 846.00M |
| March 31, 2015 | -94.00M |
| December 31, 2014 | -14.00M |
| September 30, 2014 | 18.00M |
| June 30, 2014 | 6.00M |
| March 31, 2014 | -160.00M |
| December 31, 2013 | -263.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | 17.31B |
| Insulet Corp. | -319.90M |
| Penumbra, Inc. | -1.907M |
| Intuitive Surgical, Inc. | -1.354B |
| Stryker Corp. | -1.51B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 348.00M |
| Cash from Investing (Quarterly) | -591.00M |
| Free Cash Flow | 3.475B |
| Free Cash Flow Per Share (Quarterly) | 0.1144 |
| Free Cash Flow to Equity (Quarterly) | 1.114B |
| Free Cash Flow to Firm (Quarterly) | 278.07M |
| Free Cash Flow Yield | 5.17% |